Alzamend Neuro, Inc.
ALZN· Nasdaq
Filed Jul 29, 2021 · 10-K · 90 days after period end · 0001214659-21-007963
derived · Computed from the longer spans the company filed.
no prior Q4 2020 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Apr 30, 2021 · filed Jul 29, 2021 · 90 d after period end
Alzamend Neuro, Inc. · CIK 1677077 · Engraved from SEC EDGAR